The plant will be built under a strategic alliance with ZI Base in Pudong and focus on contract manufacturing to Chinese companies developing their own drugs.
China Industrial Biotech Network, June 10, 2013
Boehringer Ingelheim to open $46 million biologics plant in Shanghai